Pfizer Central Research, Eastern Point Road, Groton, CT 06340, U.S.A.
MODULATION OF A2AADENOSINE RECEPTOR(S) BY K+ATPCHANNELS IN BOVINE BRAIN STRIATAL MEMBRANES
Article first published online: 2 JAN 2013
© The Author(s) Journal compilation © 1999 International Federation for Cell Biology
Cell Biology International
Volume 23, Issue 7, pages 519–522, July 1999
How to Cite
Olanrewaju, H. A., Marala, R. B. and Mustafa, S. J. (1999), MODULATION OF A2AADENOSINE RECEPTOR(S) BY K+ATPCHANNELS IN BOVINE BRAIN STRIATAL MEMBRANES. Cell Biology International, 23: 519–522. doi: 10.1006/cbir.1999.0378
- Issue published online: 2 JAN 2013
- Article first published online: 2 JAN 2013
- Received 11 November 1998; accepted 29 March 1999
- Cited By
- A2Aadenosine receptors;
- bovine striatal membranes;
The modulation of adenosine receptor with K+ATPchannel blocker, glibenclamide, was investigated using the radiolabeled A2A-receptor selective agonist [3H]CGS 21680. Radioligand binding studies in bovine brain striatal membranes (BBM) indicated that unlabeled CGS 21680 displaced the bound [3H]CGS 21680 in a concentration-dependent manner with a maximum displacement being approximately 65% at 10−4m. In the presence of 10−5m glibenclamide, unlabeled CGS 21680 increased the displacement of bound [3H]CGS 21860 by approximately 28% at 10−4m. [3H]CGS 21680 bound to BBM in a saturable manner to a single binding site (Kd=10.6±1.71n m; Bmax=221.4±6.43fmol/mg of protein). In contrast, [3H]CGS 21680 showed saturable binding to two sites in the presence of 10−5m glibenclamide; (Kd=1.3± 0.22n m; Bmax=74.3±2.14fmol/mg protein; and Kd=8.9±0.64n m; Bmax=243.2±5.71fmol/mg protein), indicating modulation of adenosine A2Areceptors by glibenclamide. These studies suggest that the K+ATPchannel blocker, glibenclamide, modulated the adenosine A2Areceptor in such a manner that [3H]CGS 21680 alone recognizes a single affinity adenosine receptor, but that in the presence of glibenclamide it binds to two sites. These studies provide further insight into the interactions between K+ATPchannels and adenosine receptors.